
Sign up to save your podcasts
Or


In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.
By Janus Henderson Investors4.7
1414 ratings
In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.

515 Listeners

1,174 Listeners

2,173 Listeners

1,857 Listeners

196 Listeners

12 Listeners

284 Listeners

56,429 Listeners

177 Listeners

896 Listeners

1,548 Listeners

107 Listeners

207 Listeners

303 Listeners

6 Listeners

3 Listeners